Cure Brain Cancer Foundation Rings Nasdaq Opening Bell, Announces U.S. Expansion

NEW YORK, Dec. 2, 2022 /PRNewswire/ -- Cure Brain Cancer Foundation CEO Lance Kawaguchi rang the bell to open trading on the Nasdaq stock exchange on Friday morning, December 2. The Foundation announced the establishment of an independent U.S. affiliate that will widely increase the impact of the 21-year-old, Sydney-headquartered organization—Australia's leading non-profit in brain cancer research and patient advocacy.